These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10453727)

  • 21. Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
    Hagopian GS; Mills GB; Khokhar AR; Bast RC; Siddik ZH
    Clin Cancer Res; 1999 Mar; 5(3):655-63. PubMed ID: 10100719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.
    de la Torre M; Hao XY; Larsson R; Nygren P; Tsuruo T; Mannervik B; Bergh J
    Anticancer Res; 1993; 13(5A):1425-30. PubMed ID: 7902062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terbium fluorescence studies of cisplatin binding to GH3/B6 pituitary tumor cells.
    Canada RG
    Biochim Biophys Acta; 1986 Jun; 887(1):29-34. PubMed ID: 3708009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxaliplatin induces drug resistance more rapidly than cisplatin in H69 small cell lung cancer cells.
    Stordal BK; Davey MW; Davey RA
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):256-65. PubMed ID: 16283310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.
    Chau Q; Stewart DJ
    Cancer Chemother Pharmacol; 1999; 44(3):193-202. PubMed ID: 10453720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of 5-fluorouracil cytotoxicity by cisplatin in brain tumour cell lines.
    Mineura K; Kowada M
    Cell Biol Int; 1996 May; 20(5):355-7. PubMed ID: 8688852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.
    Maiello MR; D'Alessio A; De Luca A; Carotenuto A; Rachiglio AM; Napolitano M; Cito L; Guzzo A; Normanno N
    Breast Cancer Res Treat; 2007 May; 102(3):275-82. PubMed ID: 17004112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between DNA topoisomerase II activity and cytotoxicity in pMC540 and merodantoin sensitive and resistant human breast cancer cells.
    Sharma R; Arnold L; Gulliya KS
    Anticancer Res; 1995; 15(2):295-304. PubMed ID: 7762997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro modification of cisplatin cytotoxicity with magnetic fluid.
    Chekhun VF; Yurchenko OV; Naleskina LA; Demash DV; Lukianova NY; Lozovska YV
    Exp Oncol; 2013 Mar; 35(1):15-9. PubMed ID: 23528310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
    Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
    Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
    Selvakumaran M; Pisarcik DA; Bao R; Yeung AT; Hamilton TC
    Cancer Res; 2003 Mar; 63(6):1311-6. PubMed ID: 12649192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK; Farsi K; Maslak P; Kelsen DP; Spriggs D
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding and aggregation of human mu-calpain by terbium ion.
    Raser KJ; Buroker-Kilgore M; Wang KK
    Biochim Biophys Acta; 1996 Jan; 1292(1):9-14. PubMed ID: 8547354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terbium as a luminescent probe of metal-binding sites in protein kinase C.
    Walters JD; Johnson JD
    J Biol Chem; 1990 Mar; 265(8):4223-6. PubMed ID: 2106517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipyridamole increases the cytotoxicity of cisplatin in human larynx cancer cells in vitro.
    Rodrigues M; Barbosa F; Perussi JR
    Braz J Med Biol Res; 2004 Apr; 37(4):591-9. PubMed ID: 15064823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of terbium (III) on the Ca-activated, K channel found in the resealed human erythrocyte membrane.
    Wood PG; Mueller H
    Eur J Biochem; 1985 Jan; 146(1):65-9. PubMed ID: 2578387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence of phosphotyrosine--terbium(III) complexes.
    Ringer DP; Etheredge JL; Dalrymple BL; Niedbalski JS
    Biochem Biophys Res Commun; 1990 Apr; 168(1):267-73. PubMed ID: 1691639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.